hg_58893.1

Basic information about the TSS

---

TSS ID: hg_58893.1 Species: human Chr: chr5		Start: 140175235 End: 140175262 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000644078.1 Distance: -19 GeneID: 84418 HGNC/MGI_ID: HGNC:30239 UniProt_ID: A0A2R8YEW2

Gene_name: cysteine rich transmembrane module containing 1 Gene_symbol: CYSTM1 Gene_synonyms: ORF1-FL49 Gene_source: HGNC:30239

TATA-Box annotation

---

Distance to TSS:	61
Nearest PromoterID:	NM_032412
Entrez ID:	84418
Nearest Unigene:	Hs.529798
Nearest Refseq:	NM_032412
Nearest Ensembl:	ENSG00000120306
Gene Name:	cysteine rich transmembrane module containing 1
Gene Alias:	C5orf32|ORF1-FL49
Gene Description:	cysteine rich transmembrane module containing 1
Gene Type:	protein-coding
CpG%:	0.08
GC%:	0.681592
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CYSTM1 p2@CYSTM1 p4@CYSTM1 p5@CYSTM1
Sample		p1@CYSTM1	p2@CYSTM1	p4@CYSTM1	p5@CYSTM1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	71.30	7.79	4.29	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	71.62	9.91	6.07	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	70.41	11.96	5.98	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	52.60	9.56	6.03	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	55.79	7.20	8.32	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	52.72	9.11	6.40	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	76.48	11.77	9.15	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	79.21	12.84	6.30	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	70.74	10.69	9.19	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	48.69	6.38	6.96	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	48.51	8.08	7.68	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	43.91	5.29	7.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	139.27	7.09	1.61	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	123.29	9.32	0.90	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	118.56	6.37	1.10	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	112.92	10.06	2.01	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	121.87	8.52	1.31	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	100.81	7.59	1.27	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	106.10	6.40	1.07	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	157.21	7.97	1.65	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	132.85	8.42	2.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	134.30	5.70	2.24	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	121.37	8.40	1.29	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	118.66	9.71	1.94	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	121.51	6.97	1.55	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	125.97	6.01	0.63	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	132.42	6.59	2.75	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	160.31	9.43	1.89	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	131.64	8.24	2.10	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	150.38	9.41	1.99	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	149.05	9.42	1.67	1.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	138.92	8.60	2.15	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	123.24	9.71	2.74	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	129.31	12.21	4.12	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	179.51	9.72	1.50	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	140.65	8.05	1.34	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	151.45	8.58	2.04	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	141.24	8.87	2.22	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	153.42	9.45	1.35	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	109.23	8.16	1.20	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	125.63	8.23	2.59	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	127.07	9.22	1.90	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	177.57	10.54	1.90	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	145.81	8.74	2.10	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	149.98	8.43	3.01	2.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	144.01	6.98	2.33	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	161.46	8.64	1.20	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	164.82	7.15	2.09	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	142.43	7.90	3.11	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	156.91	7.68	1.82	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	144.08	9.02	1.64	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	148.32	8.45	3.34	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	134.49	8.87	2.48	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	119.30	9.28	1.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	55.37	5.03	3.36	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	72.10	5.97	1.84	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	121.22	7.13	0.65	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	114.66	8.99	1.93	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	86.76	7.23	1.57	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	104.35	2.82	3.53	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	97.58	6.17	2.24	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	41.40	3.18	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	73.39	2.38	0.68	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	132.24	4.22	0.65	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	117.50	3.55	0.00	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	150.64	11.70	1.46	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	144.30	5.95	0.50	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	138.39	8.91	0.94	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	193.41	6.62	1.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	245.31	9.90	1.55	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	190.17	7.64	1.22	1.83
Adipocyte - breast, donor1	11376-118A8	65.41	1.11	0.48	0.95
Adipocyte - breast, donor2	11327-117E4	88.40	3.69	0.80	2.09
Adipocyte - omental, donor1	11473-119C6	61.07	1.65	0.13	0.89
Adipocyte - omental, donor2	11474-119C7	52.32	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	72.34	2.34	0.33	0.67
Adipocyte - perirenal, donor1	11476-119C9	70.18	0.64	1.28	3.19
Adipocyte - subcutaneous, donor1	11259-116F8	80.26	1.10	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	68.20	1.81	0.00	3.61
Adipocyte - subcutaneous, donor3	11408-118E4	67.43	2.09	0.17	2.78
Adipocyte differentiation, day04, donor1	13019-139D4	93.09	4.30	0.00	2.15
Adipocyte differentiation, day04, donor2	13022-139D7	64.86	1.54	0.26	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	138.83	9.48	1.67	3.35
Adipocyte differentiation, day04, donor4	13028-139E4	104.04	7.05	0.59	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	108.75	10.30	0.88	2.33
Adipocyte differentiation, day08, donor2	13023-139D8	143.63	5.49	0.65	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	108.77	4.27	0.53	2.13
Adipocyte differentiation, day08, donor4	13029-139E5	136.88	3.90	1.11	3.34
Adipocyte differentiation, day12, donor1	13021-139D6	222.50	16.64	7.07	3.33
Adipocyte differentiation, day12, donor2	13024-139D9	166.02	8.29	2.01	1.76
Adipocyte differentiation, day12, donor3	13027-139E3	137.44	8.18	2.62	1.64
Adipocyte differentiation, day12, donor4	13030-139E6	154.67	7.92	2.44	1.52
Alveolar Epithelial Cells, donor1	11510-119G7	54.81	20.77	6.19	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	138.05	26.18	7.17	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	53.91	4.79	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	5.58	0.00	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	7.60	0.41	0.21	0.41
Anulus Pulposus Cell, donor1	11248-116E6	18.42	0.23	0.11	1.03
Anulus Pulposus Cell, donor2	11463-119B5	29.63	0.24	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	47.63	3.59	1.35	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	48.62	0.87	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	49.23	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	46.93	2.09	0.60	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	44.26	1.26	0.00	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	50.17	1.32	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	37.69	0.97	0.97	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	30.10	1.46	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	41.57	0.59	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	41.05	1.13	1.13	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	42.81	0.73	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	37.61	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	38.71	2.47	0.33	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	40.94	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	33.17	1.96	0.45	1.06
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	47.69	1.07	0.00	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	37.41	0.38	0.94	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	38.22	1.87	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	33.17	0.98	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	36.16	0.50	0.17	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	45.63	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	49.56	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	37.57	1.54	0.17	1.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	34.47	0.97	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.39	1.52	0.38	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	32.71	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	31.35	0.57	1.71	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	39.33	1.50	0.21	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	43.10	1.55	0.52	1.81
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	39.41	1.41	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	39.55	2.57	0.64	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	49.23	2.85	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	40.36	1.17	1.17	2.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	43.35	1.20	0.90	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	48.71	1.19	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	40.18	1.02	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	42.02	2.04	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	38.12	2.54	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	40.56	0.86	0.43	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	42.55	0.21	0.42	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	39.15	1.74	0.87	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	42.51	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	42.21	1.86	1.02	1.86
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	57.91	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	42.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	33.66	1.07	0.86	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	40.91	1.80	1.20	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	29.16	1.46	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	35.86	1.15	0.46	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	43.36	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	48.30	2.80	0.25	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	44.59	1.45	0.83	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	30.91	1.22	0.31	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	32.50	0.48	0.96	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	38.36	0.89	0.22	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	38.14	3.05	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	35.45	0.00	2.22	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	31.25	2.38	0.53	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	31.26	1.09	1.09	1.45
Astrocyte - cerebellum, donor1	11500-119F6	32.06	0.86	0.12	1.84
Astrocyte - cerebellum, donor2	11580-120F5	28.07	0.00	0.00	1.54
Astrocyte - cerebellum, donor3	11661-122F5	43.42	0.42	0.42	2.31
Astrocyte - cerebral cortex, donor1	11235-116D2	45.66	1.05	0.00	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	40.28	1.29	0.16	1.29
Astrocyte - cerebral cortex, donor3	11392-118C6	38.93	0.75	0.00	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	236.71	9.86	1.72	1.61
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	208.34	9.52	1.13	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	204.15	7.62	1.14	1.48
Basophils, donor1	12241-129G9	33.48	6.02	2.09	0.26
Basophils, donor2	12242-129H1	23.09	3.61	1.44	0.00
Basophils, donor3	12243-129H2	17.35	2.35	1.62	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	29.97	6.25	3.23	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	61.26	5.94	3.66	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	28.69	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	39.54	3.77	2.51	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	40.13	4.78	2.50	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	53.89	8.06	2.30	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	49.13	8.82	1.80	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	32.87	5.36	4.43	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	87.34	6.52	1.86	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	15.67	0.64	0.64	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	17.47	0.00	2.25	0.00
CD14+ Monocytes, donor2	11305-117B9	20.04	0.74	1.67	0.37
CD14+ Monocytes, donor3	11381-118B4	23.71	2.41	1.54	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	107.84	0.85	0.00	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	105.00	1.52	0.00	3.41
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	75.28	0.00	0.00	2.30
CD14+ monocytes - mock treated, donor1	11863-125A9	49.87	2.60	1.01	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	34.70	2.41	1.81	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	43.59	4.03	1.90	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	62.61	3.18	1.00	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	51.89	5.24	1.93	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	86.53	13.64	3.97	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	65.98	5.09	0.59	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	52.35	3.74	0.36	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	71.60	8.05	4.35	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	68.36	6.32	3.51	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	61.78	10.03	4.22	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	84.31	16.64	7.77	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	56.38	3.87	1.93	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	46.49	4.59	2.39	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	68.71	9.79	3.54	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	80.30	10.30	2.52	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	53.61	9.50	2.71	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	57.18	12.22	4.80	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	49.76	3.23	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	44.84	1.40	1.40	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	48.82	3.79	1.68	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	60.07	6.98	2.02	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	37.34	3.17	0.70	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	49.14	4.39	1.75	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	64.52	5.06	2.62	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	49.80	4.09	1.12	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	81.48	12.72	6.25	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	52.82	4.09	2.46	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	40.56	4.64	1.85	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	56.61	6.26	3.25	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	23.54	0.22	0.65	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	24.25	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	26.86	1.30	0.65	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	32.55	1.40	0.62	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	28.47	0.17	0.17	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	25.20	0.67	0.22	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	33.68	1.28	0.51	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	25.25	0.44	0.44	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	23.79	0.63	0.21	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	24.41	1.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	18.64	2.07	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	23.45	4.26	1.07	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	15.55	1.07	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	16.14	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	23.53	1.57	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	32.96	0.00	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	25.48	7.40	10.68	0.00
CD19+ B Cells, donor2	11624-122B4	26.12	5.08	5.08	0.00
CD19+ B Cells, donor3	11705-123B4	33.32	9.59	5.05	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	149.91	33.13	8.89	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	132.63	21.97	7.99	0.80
CD34+ Progenitors, donor1	11545-120B6	8.03	3.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	15.73	2.81	3.37	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	9.02	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	9.92	0.23	0.68	0.45
CD4+ T Cells, donor1	11225-116C1	14.28	6.43	12.50	0.00
CD4+ T Cells, donor2	11306-117C1	25.11	7.96	13.47	0.00
CD4+ T Cells, donor3	11382-118B5	24.40	13.72	18.91	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	22.72	2.30	0.77	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	17.52	1.12	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	17.25	0.86	0.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	13.75	6.16	6.16	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	11.94	4.92	3.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	17.34	1.30	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	30.33	2.37	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	25.15	1.29	0.81	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	21.07	2.69	4.93	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	20.26	3.84	1.75	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	15.40	1.32	1.76	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	8.43	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	11.43	0.42	0.21	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	8.35	0.33	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	20.94	8.43	6.53	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	15.54	9.11	5.36	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	17.93	8.97	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	15.02	0.56	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	18.85	1.52	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	12.19	1.05	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	23.26	11.12	11.12	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	34.23	9.96	11.70	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	22.66	5.67	8.28	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	13.36	0.00	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	14.77	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	18.15	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	11.35	0.83	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	8.83	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	24.64	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	16.12	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	24.93	1.38	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	18.99	8.84	14.41	0.00
CD8+ T Cells, donor2	11307-117C2	19.52	6.76	13.89	0.00
CD8+ T Cells, donor3	11383-118B6	23.99	7.07	10.60	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	100.24	17.20	7.11	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	79.56	19.41	5.99	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	88.64	14.23	7.11	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	136.60	30.92	12.91	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	108.71	20.16	9.36	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	101.87	22.97	6.37	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	93.21	18.47	7.82	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	79.49	16.85	4.21	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	83.49	17.12	8.44	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	94.79	23.55	7.55	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	100.22	15.11	6.39	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	96.18	21.85	6.39	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	126.07	35.02	14.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	138.45	38.26	19.13	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	103.68	44.75	17.16	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	110.21	28.09	8.64	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	108.76	20.72	7.77	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	107.48	22.16	4.24	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	98.87	25.04	10.14	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	95.04	20.30	4.61	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	79.83	22.12	4.81	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	102.88	27.54	9.18	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	93.40	19.71	12.22	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	95.31	24.96	12.10	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	202.34	61.02	24.09	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	176.26	49.66	25.88	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	230.40	71.12	27.05	1.00
Cardiac Myocyte, donor1	11525-119I4	53.00	1.83	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	26.68	1.48	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	43.57	3.37	0.11	0.84
Chondrocyte - de diff, donor1	11261-116G1	33.63	0.35	0.69	1.39
Chondrocyte - de diff, donor2	11338-117F6	34.47	0.36	0.36	1.07
Chondrocyte - de diff, donor3	11410-118E6	42.78	1.02	0.11	1.14
Chondrocyte - re diff, donor2	11339-117F7	51.03	0.90	0.90	1.79
Chondrocyte - re diff, donor3	11411-118E7	36.80	1.21	0.40	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	75.63	4.82	1.38	1.72
Ciliary Epithelial Cells, donor2	11323-117D9	60.71	2.57	0.86	2.57
Ciliary Epithelial Cells, donor3	11399-118D4	65.58	3.72	0.80	0.88
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	144.15	24.30	14.12	1.47
Corneal Epithelial Cells, donor1	11526-119I5	88.05	15.59	4.39	0.22
Corneal Epithelial Cells, donor2	11606-120I4	37.54	7.96	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	78.73	9.97	5.88	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	55.64	0.83	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	56.14	0.63	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	88.77	1.84	0.54	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	51.93	2.73	3.07	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	66.59	5.88	3.92	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	61.94	2.90	3.39	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	46.20	1.50	0.00	1.50
Endothelial Cells - Aortic, donor1	11263-116G3	63.96	0.59	0.00	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	39.31	0.85	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	57.80	1.57	0.00	1.18
Endothelial Cells - Artery, donor1	11264-116G4	90.46	2.62	0.00	2.91
Endothelial Cells - Artery, donor2	11341-117F9	61.88	0.24	0.47	1.65
Endothelial Cells - Artery, donor3	11413-118E9	55.22	0.35	0.35	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	76.69	2.22	0.66	1.99
Endothelial Cells - Lymphatic, donor2	11317-117D3	105.28	2.43	0.30	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	70.48	1.41	0.00	1.97
Endothelial Cells - Microvascular, donor1	11265-116G5	51.11	1.78	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	52.07	2.60	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	44.95	1.28	0.00	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	69.62	0.80	0.00	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	50.32	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	54.17	1.49	0.12	1.74
Endothelial Cells - Umbilical vein, donor2	11324-117E1	63.22	0.65	0.00	1.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	61.80	0.37	0.00	1.71
Endothelial Cells - Vein, donor1	11267-116G7	37.54	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	36.32	0.00	0.00	1.40
Endothelial Cells - Vein, donor3	11416-118F3	53.07	0.47	0.00	1.88
Eosinophils, donor1	12244-129H3	137.22	60.99	0.00	0.00
Eosinophils, donor2	12245-129H4	316.85	84.16	26.40	0.00
Eosinophils, donor3	12246-129H5	424.45	85.60	57.07	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	32.01	3.91	1.47	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	6.24	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	36.13	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	144.74	8.21	2.85	2.74
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	116.14	3.47	0.76	3.47
Fibroblast - Aortic Adventitial, donor1	11245-116E3	54.94	1.94	0.73	2.06
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	76.83	4.37	0.82	1.91
Fibroblast - Aortic Adventitial, donor2	11326-117E3	86.38	3.90	1.16	2.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	45.85	0.53	0.26	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	65.78	4.65	0.66	1.33
Fibroblast - Cardiac, donor1	11268-116G8	44.46	2.27	0.91	0.45
Fibroblast - Cardiac, donor2	11345-117G4	33.35	2.27	0.00	2.27
Fibroblast - Cardiac, donor3	11417-118F4	56.62	2.68	0.79	1.73
Fibroblast - Cardiac, donor4	11452-119A3	44.25	1.21	0.91	2.12
Fibroblast - Cardiac, donor5	11456-119A7	69.42	1.02	0.38	2.54
Fibroblast - Cardiac, donor6	11460-119B2	43.20	0.61	0.15	1.52
Fibroblast - Choroid Plexus, donor1	11492-119E7	26.13	0.27	0.00	2.01
Fibroblast - Choroid Plexus, donor2	11572-120E6	19.85	0.00	0.43	2.59
Fibroblast - Choroid Plexus, donor3	11653-122E6	58.59	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	51.43	1.15	0.23	1.85
Fibroblast - Conjunctival, donor3	11692-122I9	55.46	0.17	0.00	2.20
Fibroblast - Dermal, donor1	11269-116G9	87.10	2.35	0.47	1.64
Fibroblast - Dermal, donor2	11346-117G5	53.77	1.89	0.00	1.89
Fibroblast - Dermal, donor3	11418-118F5	68.18	2.54	0.24	1.93
Fibroblast - Dermal, donor4	11450-119A1	34.59	0.57	0.00	1.36
Fibroblast - Dermal, donor5	11454-119A5	40.65	0.17	0.00	2.44
Fibroblast - Dermal, donor6	11458-119A9	33.46	0.16	0.00	2.27
Fibroblast - Gingival, donor1	11237-116D4	38.94	0.21	0.42	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	27.25	0.00	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	14.23	0.00	0.00	0.53
Fibroblast - Gingival, donor3	11394-118C8	66.81	0.68	0.10	2.22
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	29.09	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	32.60	0.00	0.00	2.29
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	23.70	0.00	0.00	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	20.15	0.14	0.00	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	8.12	0.00	0.35	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	20.04	0.29	0.00	2.49
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	18.54	0.00	0.27	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	19.42	0.33	0.00	1.32
Fibroblast - Gingival, donor9 (control)	11927-125I1	21.86	0.15	0.00	0.88
Fibroblast - Lung, donor1	11270-116H1	17.67	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	38.41	0.84	0.21	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	59.14	0.00	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	44.76	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	43.94	0.00	0.00	1.40
Fibroblast - Mammary, donor1	11540-120B1	40.19	0.81	1.62	1.62
Fibroblast - Mammary, donor2	11620-122A9	55.92	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	20.95	0.00	0.19	1.16
Fibroblast - Periodontal Ligament, donor2	11319-117D5	21.69	0.15	0.00	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	31.21	0.61	0.31	1.84
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	26.71	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	36.72	0.81	0.27	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	45.11	0.93	0.23	2.20
Fibroblast - Pulmonary Artery, donor1	11250-116E8	44.54	2.43	0.33	1.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	59.74	1.42	0.20	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	38.09	0.67	0.00	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	52.58	0.40	0.00	1.98
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	15.48	0.20	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	22.56	0.53	0.00	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	30.94	0.79	0.20	1.58
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.35	0.90	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	28.39	0.65	0.22	1.51
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	24.55	0.51	0.00	1.27
Fibroblast - skin normal, donor1	11553-120C5	36.75	0.82	0.00	1.80
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	20.85	1.40	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	29.23	0.50	0.20	1.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	23.57	0.00	0.00	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	27.92	0.50	0.00	1.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	31.28	0.34	0.34	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	15.11	0.66	0.00	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	32.28	0.75	0.11	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	20.92	0.00	0.00	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	23.21	0.47	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	6.10	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	50.45	10.57	1.91	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	29.93	6.51	2.60	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	35.01	7.67	4.34	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	26.03	1.53	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	35.09	5.10	1.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	53.63	4.85	1.43	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	93.48	1.38	1.10	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	50.92	2.05	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	54.09	3.57	1.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	84.32	2.38	1.32	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	45.01	2.28	0.33	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	42.90	6.63	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	41.27	4.10	2.40	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	52.70	3.94	1.85	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	48.62	6.18	1.34	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	78.55	4.71	2.23	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	73.23	4.29	2.63	1.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	68.92	5.08	2.64	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	81.92	5.48	2.51	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	75.36	5.61	2.62	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	89.40	6.12	2.40	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	94.26	5.02	0.59	4.14
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	71.05	3.50	1.91	2.38
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	90.04	6.70	1.79	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	67.95	2.82	0.40	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	73.96	2.71	1.87	2.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	69.52	7.54	3.01	0.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	75.34	2.39	0.21	1.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	73.26	3.24	0.85	3.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	83.65	1.88	0.44	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	67.06	7.49	2.50	1.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	78.20	5.72	2.86	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	84.79	2.06	0.62	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	70.33	1.84	0.81	1.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	97.39	6.50	0.33	3.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	84.20	2.42	0.22	3.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	105.04	3.07	0.37	2.46
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	97.09	5.19	1.62	2.11
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	100.06	1.92	1.28	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	89.35	2.75	1.14	1.23
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	123.22	5.38	0.47	1.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	93.35	4.87	1.22	2.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	103.49	3.35	1.25	2.51
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	129.10	9.44	2.42	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	105.77	5.05	1.12	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	90.36	3.70	1.11	2.13
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	133.97	11.50	2.67	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	117.97	5.51	1.99	1.38
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	122.41	4.92	1.42	2.33
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	178.64	11.39	3.25	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	89.96	3.87	0.55	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	87.94	5.04	0.88	1.97
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	130.91	5.95	0.99	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	61.60	1.85	0.53	1.32
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	58.71	1.21	0.20	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	74.47	4.83	2.03	2.29
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	40.01	3.78	2.79	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	55.62	3.39	2.47	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	42.55	4.71	3.48	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	42.56	3.76	3.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	36.17	4.24	1.98	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	38.74	1.84	3.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	64.34	7.42	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	43.32	3.87	2.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	38.51	4.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	43.47	8.69	3.48	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	44.92	2.60	2.60	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	51.48	4.12	1.24	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	53.32	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	39.71	3.64	0.84	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	41.51	3.60	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	45.30	5.03	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	44.85	2.54	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	42.12	3.06	2.04	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	58.47	4.18	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	53.83	2.29	2.29	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	34.04	3.26	0.59	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	37.27	0.00	3.39	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	35.21	2.07	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	29.69	2.07	0.92	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	30.75	1.54	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	29.01	1.63	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	51.50	2.68	0.00	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	53.55	1.54	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	39.03	0.68	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	96.91	7.45	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	50.02	2.36	0.47	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	44.06	0.00	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	49.34	2.03	2.54	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	51.85	2.39	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	57.23	1.48	0.49	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	73.19	2.36	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	50.18	4.08	1.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	74.17	3.51	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	62.73	2.54	2.54	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	47.16	3.58	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	28.63	1.94	0.00	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	23.29	0.00	0.00	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	31.48	0.00	0.00	5.62
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	30.45	0.32	0.00	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	52.64	1.25	0.84	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	62.31	8.94	2.67	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	73.94	7.76	3.38	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	65.52	10.24	4.55	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	69.19	8.20	3.72	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	63.40	6.88	2.79	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	60.28	12.70	4.31	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	73.73	10.34	3.86	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	69.65	8.92	3.26	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	81.69	10.89	3.52	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	72.75	0.56	0.56	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	46.74	2.16	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	68.74	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	46.91	2.12	2.12	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	39.23	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	33.92	1.57	0.17	1.05
Hepatocyte, donor1	11523-119I2	54.48	12.11	2.42	0.00
Hepatocyte, donor2	11603-120I1	64.64	4.31	3.23	1.08
Hepatocyte, donor3	11684-122I1	49.70	1.23	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	20.23	0.65	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	108.36	36.70	15.38	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	76.29	5.76	0.96	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	82.78	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	126.83	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	91.37	4.15	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	127.64	2.50	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	142.42	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	97.39	2.56	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	155.41	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	134.82	6.50	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	108.37	11.67	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	119.81	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	108.52	5.29	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	110.86	2.22	5.54	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	146.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	106.45	4.41	1.26	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	94.34	3.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	160.98	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	91.09	4.52	0.65	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	99.82	6.44	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	107.53	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	91.27	2.44	3.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	70.11	5.46	2.52	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	143.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	93.23	4.02	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	104.33	1.85	3.69	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	30.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	101.96	3.78	5.66	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	90.70	4.53	1.81	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	132.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	82.86	6.46	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	110.53	8.89	2.54	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	80.35	8.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	91.13	3.65	5.47	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	15.80	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	89.97	4.28	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	106.19	3.32	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	103.40	7.41	4.63	1.54
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	73.75	7.02	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	141.44	6.29	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	59.80	4.17	2.09	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	112.87	15.49	2.21	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	155.62	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	90.68	4.36	0.87	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	105.74	13.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	132.41	0.00	3.48	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	104.54	9.60	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	90.05	9.70	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	76.94	8.55	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	69.95	2.76	2.76	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	130.09	15.13	3.03	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	167.63	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	122.66	7.40	3.17	1.06
Keratinocyte - epidermal, donor1	11272-116H3	33.05	9.22	4.57	0.08
Keratinocyte - epidermal, donor2	11349-117G8	36.31	4.69	3.51	0.00
Keratinocyte - epidermal, donor3	11421-118F8	55.00	8.52	2.27	0.09
Keratinocyte - oral, donor1	11251-116E9	51.31	6.81	1.48	0.11
Keratocytes, donor1	11527-119I6	140.63	2.06	0.34	1.72
Keratocytes, donor2	11607-120I5	37.50	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	80.82	0.40	0.20	1.98
Krukenberg tumor cell line:HSKTC	10687-109F3	87.92	8.79	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	73.35	1.08	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	128.02	11.65	1.73	2.08
Lens Epithelial Cells, donor3	11690-122I7	27.45	1.21	0.20	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	75.65	2.37	0.59	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	59.72	1.95	0.00	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	66.11	1.73	0.79	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	84.96	2.15	0.00	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	70.28	0.00	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	70.08	1.94	0.54	1.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	78.38	0.41	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	73.06	1.52	0.25	1.52
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	65.73	2.25	0.28	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	79.50	1.98	0.00	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	70.19	1.74	0.19	1.36
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	62.02	2.78	0.19	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	79.79	3.48	0.35	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	69.41	0.72	0.48	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	70.46	1.37	0.14	1.51
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	75.76	2.46	0.62	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	63.91	2.49	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	75.76	2.56	0.00	2.01
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	85.24	2.63	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	68.82	0.00	0.00	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	72.94	2.99	0.50	1.74
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	78.56	2.42	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	74.33	1.08	0.00	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	76.60	1.36	0.45	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	85.54	3.11	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	72.45	1.68	0.00	1.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	72.18	1.95	0.15	1.95
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	98.37	3.44	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	76.39	1.51	0.19	1.51
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	65.84	1.48	0.32	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	84.32	0.48	0.97	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	77.74	0.99	0.00	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	69.01	1.24	0.62	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	82.19	1.85	0.00	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	68.44	0.99	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	69.71	1.65	0.00	1.10
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	77.51	2.57	0.00	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	79.13	0.61	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	78.10	1.96	0.56	1.68
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	78.58	1.07	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	90.65	2.91	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	68.93	0.93	0.16	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	94.18	2.51	0.72	4.30
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	73.18	2.29	0.65	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	65.92	1.88	0.00	1.65
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	75.12	2.48	0.12	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	70.69	2.56	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	77.27	1.79	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	32.99	6.14	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	25.24	1.48	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	25.81	2.96	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	23.21	2.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	37.36	2.80	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	28.34	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	34.49	3.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	23.75	3.39	0.68	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	37.52	3.49	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	33.76	3.15	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	25.06	2.44	0.95	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	23.62	4.62	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	35.29	4.94	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	32.65	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	34.64	1.53	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	36.02	5.07	1.07	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	38.92	5.29	0.76	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	25.77	1.23	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	33.43	1.63	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	36.03	4.79	0.83	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	28.03	3.36	1.12	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	23.70	3.09	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	31.64	4.06	2.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	33.18	1.20	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	28.77	2.77	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	29.34	4.24	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.23	1.84	2.21	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	33.39	3.45	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	31.08	2.69	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	25.48	3.96	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	31.18	6.56	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	29.82	4.52	2.26	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	28.73	2.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	31.37	2.24	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	26.01	3.34	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	35.32	2.15	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	32.54	1.71	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	27.65	3.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.13	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	25.60	2.13	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	27.50	2.06	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	26.30	1.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	24.91	1.35	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.93	3.33	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	23.26	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	32.79	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	28.41	8.00	1.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	26.17	3.63	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	15.33	3.07	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	29.10	1.97	2.47	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	26.35	0.94	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	29.16	1.01	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	22.53	3.60	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	17.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	26.72	1.78	2.67	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	28.94	2.35	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	25.73	2.64	1.32	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	29.58	2.08	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	27.57	4.81	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	26.28	3.91	1.12	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	27.38	3.09	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	35.49	3.86	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	28.86	1.52	2.03	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	29.32	4.33	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	31.80	3.18	1.19	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	24.91	1.82	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	30.43	1.38	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	32.68	3.42	1.14	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	26.85	1.55	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	26.00	4.84	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	34.86	1.27	1.58	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	27.72	3.20	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	24.71	2.87	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	28.28	4.63	1.03	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.98	2.83	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	35.75	3.40	1.70	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	30.37	3.74	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	38.37	0.00	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	25.05	0.42	1.67	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	23.70	3.72	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	29.44	0.67	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	29.41	2.67	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	25.05	2.83	0.81	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	24.78	2.75	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	19.56	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	28.49	2.85	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	24.54	3.83	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	36.11	3.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	31.63	1.34	1.34	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	24.18	4.68	1.04	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	31.83	1.33	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	6.24	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	102.79	0.68	0.00	2.05
Macrophage - monocyte derived, donor2	11313-117C8	187.91	6.42	0.92	2.02
Macrophage - monocyte derived, donor3	11389-118C3	170.80	2.49	0.52	2.36
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	64.78	18.05	7.97	0.00
Mallassez-derived cells, donor2	11929-125I3	33.12	7.29	1.11	0.00
Mallassez-derived cells, donor3	11930-125I4	54.21	13.06	5.70	0.28
Mammary Epithelial Cell, donor1	11273-116H4	31.49	9.17	3.29	0.30
Mammary Epithelial Cell, donor2	11350-117G9	36.48	6.37	3.19	0.00
Mammary Epithelial Cell, donor3	11422-118F9	17.46	1.25	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	151.86	3.39	0.68	0.68
Mast cell, donor1	11563-120D6	107.28	3.03	0.43	1.41
Mast cell, donor2	11565-120D8	115.90	8.92	2.67	1.19
Mast cell, donor3	11566-120D9	133.05	3.15	0.68	1.35
Mast cell, donor4	11567-120E1	127.83	7.27	4.43	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	121.10	2.11	0.55	1.66
Mast cell, expanded and stimulated, donor8	11942-126A7	105.65	1.75	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	160.50	1.84	0.34	2.41
Mast cell, expanded, donor8	11941-126A6	78.16	2.18	0.00	0.33
Melanocyte - dark, donor1	11502-119F8	52.93	1.79	0.00	0.40
Melanocyte - dark, donor2	11582-120F7	24.57	1.04	0.00	1.38
Melanocyte - dark, donor3	11663-122F7	159.95	11.66	1.59	2.54
Melanocyte - light, donor1	11274-116H5	76.16	4.00	0.94	1.65
Melanocyte - light, donor2	11351-117H1	94.18	2.05	0.68	1.36
Melanocyte - light, donor3	11423-118G1	71.98	0.87	0.87	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	149.52	3.85	0.94	2.92
Melanocyte, donor2 (MC+2)	12739-135I3	194.98	11.30	3.50	2.15
Melanocyte, donor3 (MC+3)	12837-137B2	180.80	11.25	1.07	2.95
Meningeal Cells, donor1	11493-119E8	39.58	0.50	0.12	2.11
Meningeal Cells, donor2	11573-120E7	38.29	0.88	0.00	1.32
Meningeal Cells, donor3	11654-122E7	25.35	0.65	0.08	1.30
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	18.25	0.00	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	41.26	1.31	0.30	1.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	88.05	3.94	0.00	6.57
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	95.50	1.31	1.31	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	57.41	2.15	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	56.97	2.12	0.00	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	65.34	1.51	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	17.80	0.00	0.22	1.54
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	29.95	0.00	0.73	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	20.66	0.20	0.00	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	23.13	0.28	0.00	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	72.49	3.72	1.12	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	34.47	0.92	0.39	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	19.29	0.30	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	23.69	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	44.66	1.42	0.35	2.13
Mesenchymal stem cells - hepatic, donor0	11218-116B3	27.52	1.25	0.00	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	16.69	0.00	0.00	1.45
Mesothelial Cells, donor1	11247-116E5	195.43	43.49	18.56	0.80
Mesothelial Cells, donor2	12156-128G5	161.65	35.03	13.01	1.00
Mesothelial Cells, donor3	11402-118D7	213.61	43.43	11.85	1.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	79.67	0.00	0.00	4.05
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	210.07	4.43	1.23	2.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	277.09	6.18	0.59	2.65
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	194.03	3.72	1.24	3.10
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	246.43	5.81	1.04	2.28
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	229.99	4.00	0.75	3.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	228.55	7.45	1.40	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	204.23	4.06	1.22	3.25
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	224.51	5.15	1.19	1.98
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	169.02	7.08	1.77	3.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	333.96	7.60	0.76	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	39.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	178.06	3.61	1.27	3.18
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	115.10	1.84	0.00	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	138.60	2.09	1.19	1.79
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	114.01	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	218.03	4.52	1.25	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	221.03	6.65	0.95	1.90
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	40.91	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	202.85	2.76	1.15	1.84
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	251.57	5.05	1.26	1.89
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	164.69	3.06	1.02	2.24
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	210.25	5.79	0.86	2.36
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	220.07	6.45	0.89	1.33
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	167.55	3.50	0.44	1.97
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	166.28	3.04	1.01	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	39.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	121.76	3.81	0.54	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	211.15	4.71	0.59	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	37.07	0.00	1.09	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	166.27	1.44	0.00	2.88
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	245.74	7.20	0.80	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	54.85	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	195.73	6.01	0.50	3.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	323.37	0.00	0.00	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	103.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	190.93	6.13	0.44	2.63
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	92.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	64.04	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	244.45	5.21	2.23	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	102.30	0.70	0.00	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	106.07	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	265.30	8.21	1.37	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	102.84	1.31	0.44	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	88.42	1.42	0.71	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	284.20	8.42	0.84	4.49
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	152.54	2.49	0.42	2.49
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	96.15	1.17	0.58	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	179.49	4.52	1.21	2.11
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	287.17	7.51	2.09	3.76
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	115.50	0.00	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	114.52	4.62	0.00	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	218.54	8.54	0.00	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	152.69	2.90	0.97	2.35
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	238.93	8.81	1.55	2.59
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	276.69	6.01	1.72	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	77.49	0.00	0.00	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	122.24	4.27	0.27	1.33
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	345.43	10.48	1.20	2.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	116.68	1.41	0.42	2.12
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	252.26	7.96	2.87	2.55
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	282.16	10.39	1.77	1.77
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	114.90	2.65	0.76	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	223.88	4.26	1.14	2.56
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	368.71	12.78	1.47	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	102.96	0.65	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	177.59	3.82	0.88	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	371.94	12.69	0.86	3.75
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	129.00	1.65	1.65	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	166.46	4.47	0.30	1.79
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	229.78	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	190.70	3.56	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	190.57	2.30	0.00	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	184.09	0.00	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	144.71	1.38	0.59	2.77
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	230.04	2.79	0.00	3.73
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	164.86	1.50	0.75	3.76
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	236.51	2.13	0.80	3.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	103.37	0.90	0.00	1.24
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	167.97	0.74	0.00	4.42
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	144.37	1.83	0.37	2.56
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	191.34	1.56	1.56	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	181.17	1.60	0.53	2.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	204.79	3.86	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	171.69	2.02	0.00	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	261.42	2.53	0.84	2.95
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	311.88	2.72	1.36	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	376.39	8.90	1.27	1.91
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	397.63	7.29	2.43	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	518.08	4.53	1.51	9.06
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	782.99	26.10	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	251.88	19.01	4.75	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	188.24	12.55	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	56.23	1.72	0.65	3.66
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	82.57	1.05	0.52	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	62.74	0.67	0.00	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	51.75	0.42	0.00	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	46.20	1.14	0.57	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	46.28	3.19	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	56.44	0.00	0.00	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	43.95	1.26	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	89.49	1.16	0.46	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	71.07	0.81	0.27	2.43
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	29.22	0.63	0.00	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	77.93	0.99	0.00	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	25.17	0.54	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	80.93	0.91	0.00	2.72
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	60.10	0.65	0.00	1.63
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	27.70	1.28	0.18	1.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	43.50	1.06	0.00	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	46.22	0.60	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	19.69	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	47.81	0.65	0.49	1.63
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	21.17	0.35	0.00	1.23
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	26.72	0.70	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	43.67	0.00	0.00	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	37.60	0.64	0.32	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	30.01	3.45	0.69	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	18.05	0.00	0.00	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	26.25	0.42	0.00	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	37.74	0.71	0.24	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	44.64	1.29	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	70.98	1.00	0.00	2.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.53	0.45	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	27.38	0.40	0.40	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	52.93	0.00	0.93	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	40.49	0.00	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	40.41	0.33	0.33	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	56.65	0.44	0.00	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.97	1.36	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	41.45	0.88	0.88	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	39.89	0.66	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	65.48	0.99	0.00	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	31.39	0.77	0.00	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	41.74	1.21	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	24.98	0.44	0.00	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	39.98	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	56.70	2.44	0.61	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	27.07	0.00	0.00	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	60.83	0.00	0.00	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	46.68	0.00	1.58	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	22.67	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	38.76	1.74	0.37	0.75
Myoblast, donor2	11322-117D8	38.55	1.53	0.19	1.73
Myoblast, donor3	11398-118D3	21.52	1.51	0.34	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	80.85	1.90	0.29	0.44
Natural Killer Cells, donor1	11230-116C6	19.37	5.54	11.99	0.00
Natural Killer Cells, donor2	11311-117C6	15.98	3.92	6.63	0.00
Natural Killer Cells, donor3	11387-118C1	23.74	7.55	7.91	0.00
Neural stem cells, donor1	11275-116H6	72.59	2.18	1.09	4.36
Neural stem cells, donor2	11352-117H2	55.84	0.00	0.00	7.70
Neurons, donor1	11494-119E9	54.62	1.14	1.14	2.28
Neurons, donor2	11574-120E8	40.95	1.32	0.44	0.88
Neurons, donor3	11655-122E8	72.35	2.47	0.00	2.47
Neutrophils, donor1	11233-116C9	182.82	25.98	9.28	0.00
Neutrophils, donor2	11314-117C9	173.93	14.49	5.80	0.00
Neutrophils, donor3	11390-118C4	466.07	89.79	17.71	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	19.71	0.24	0.00	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	25.07	0.00	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	42.32	0.60	0.00	2.01
Olfactory epithelial cells, donor1	11933-125I7	28.77	0.14	0.00	1.79
Olfactory epithelial cells, donor2	11934-125I8	30.83	0.29	0.29	1.30
Olfactory epithelial cells, donor3	11935-125I9	26.45	0.68	0.23	0.91
Olfactory epithelial cells, donor4	11936-126A1	37.11	0.29	0.00	1.07
Oligodendrocyte - precursors, donor1	11496-119F2	135.41	57.77	16.85	0.00
Osteoblast - differentiated, donor1	11276-116H7	54.45	1.06	0.64	2.55
Osteoblast - differentiated, donor2	11353-117H3	73.16	3.43	3.43	1.14
Osteoblast - differentiated, donor3	11425-118G3	94.97	1.86	0.00	3.72
Osteoblast, donor1	11277-116H8	13.09	0.20	0.00	0.39
Osteoblast, donor2	11354-117H4	22.47	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	25.59	0.00	0.53	0.89
Pancreatic stromal cells, donor1	11249-116E7	48.01	1.01	0.08	1.43
Pericytes, donor1	11491-119E6	64.31	1.00	0.00	4.12
Pericytes, donor2	11571-120E5	38.48	0.45	0.00	2.49
Pericytes, donor3	11652-122E5	25.84	0.61	0.20	0.61
Perineurial Cells, donor1	11499-119F5	31.87	0.90	0.00	1.24
Perineurial Cells, donor2	11579-120F4	23.09	0.74	0.09	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	23.27	2.55	5.10	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	30.61	6.12	4.65	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	19.54	4.79	4.01	0.26
Placental Epithelial Cells, donor1	11278-116H9	6.94	3.11	0.96	0.00
Placental Epithelial Cells, donor2	11355-117H5	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	5.10	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	56.64	2.85	1.90	1.27
Preadipocyte - breast, donor1	11467-119B9	52.34	1.88	0.56	1.69
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	27.15	0.65	0.00	0.39
Preadipocyte - breast, donor2	11328-117E5	61.69	0.90	0.23	1.35
Preadipocyte - omental, donor1	11468-119C1	59.14	1.60	0.43	1.70
Preadipocyte - omental, donor2	11329-117E6	43.65	1.31	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	66.04	2.29	0.29	2.01
Preadipocyte - perirenal, donor1	11469-119C2	65.95	2.95	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	32.25	0.31	0.31	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	27.62	0.53	0.00	2.12
Preadipocyte - subcutaneous, donor3	11428-118G6	50.23	1.36	0.34	1.87
Preadipocyte - visceral, donor1	11280-116I2	52.07	1.30	0.56	1.96
Preadipocyte - visceral, donor2	11357-117H7	56.14	0.00	0.46	1.38
Preadipocyte - visceral, donor3	11429-118G7	47.75	0.94	0.73	1.67
Prostate Epithelial Cells (polarized), donor1	11253-116F2	61.10	15.54	8.90	0.15
Prostate Epithelial Cells, donor2	11331-117E8	36.83	7.04	2.71	0.14
Prostate Epithelial Cells, donor3	11404-118D9	127.37	37.66	7.84	0.31
Prostate Stromal Cells, donor1	11254-116F3	39.98	1.25	0.11	0.91
Prostate Stromal Cells, donor2	11332-117E9	65.44	2.33	0.18	1.43
Prostate Stromal Cells, donor3	11405-118E1	74.14	1.77	0.42	2.61
Renal Cortical Epithelial Cells, donor1	11516-119H4	175.19	21.90	5.84	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	151.24	21.76	4.57	0.76
Renal Epithelial Cells, donor1	11517-119H5	91.81	6.59	1.52	1.52
Renal Epithelial Cells, donor2	11597-120H4	86.78	14.23	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	104.49	11.75	2.75	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	84.43	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	101.88	0.81	0.00	2.43
Renal Glomerular Endothelial Cells, donor3	11675-122H1	20.65	0.22	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	67.21	2.66	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	62.51	4.18	0.66	1.10
Renal Mesangial Cells, donor2	11598-120H5	99.69	3.13	1.25	0.63
Renal Mesangial Cells, donor3	11679-122H5	104.58	6.10	2.22	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	259.83	48.32	11.81	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	301.93	58.19	16.45	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	68.46	5.98	1.16	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	193.68	16.08	2.59	1.56
Retinal Pigment Epithelial Cells, donor1	11528-119I7	146.95	18.19	3.13	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	170.83	13.38	5.15	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	148.54	12.29	2.01	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	75.64	12.56	7.48	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	35.74	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	58.34	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	31.32	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	16.12	0.13	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	32.17	0.50	0.40	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	32.01	0.89	0.22	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	31.01	0.25	0.12	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	37.76	0.47	0.12	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	36.98	0.23	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	26.15	0.41	0.27	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	31.46	0.76	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	35.84	0.54	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	32.28	0.43	0.14	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	34.66	0.75	0.00	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	37.62	0.89	0.00	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	23.13	0.19	0.19	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	27.95	0.75	0.09	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	35.51	0.56	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	27.74	0.13	0.27	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	24.63	0.39	0.10	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	33.99	0.57	0.38	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	26.91	0.21	0.00	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	29.15	0.28	0.00	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	32.47	0.51	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	24.07	0.18	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	30.54	0.49	0.25	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	34.92	0.67	0.00	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	31.37	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	32.54	0.60	0.00	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	33.91	0.23	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	29.03	0.00	0.00	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	33.62	0.88	0.22	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	24.86	0.42	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	34.45	0.54	0.00	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	22.14	0.34	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	25.45	0.39	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	29.23	0.17	0.17	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	19.62	0.41	0.00	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	23.31	0.66	0.16	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	27.61	0.17	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	30.18	0.59	0.30	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	29.85	0.00	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	34.29	0.28	0.00	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	45.48	0.48	0.00	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	39.10	0.40	0.20	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	53.40	0.57	0.47	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	55.20	1.05	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	39.89	0.30	0.30	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	59.24	0.86	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	51.23	1.02	0.44	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	64.49	0.61	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	58.77	0.30	0.60	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	56.09	1.81	0.23	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	59.61	1.80	0.00	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	39.44	0.94	0.24	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	49.73	1.28	1.07	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	63.70	1.80	0.60	0.60
Schwann Cells, donor1	11498-119F4	47.21	0.19	0.19	2.63
Schwann Cells, donor2	11578-120F3	30.62	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	44.69	0.66	0.22	1.53
Sebocyte, donor1	11220-116B5	22.46	7.12	1.10	0.00
Sebocyte, donor2	11301-117B5	29.41	5.06	1.84	0.46
Sebocyte, donor3	11378-118B1	40.40	5.36	1.24	0.41
Sertoli Cells, donor1	11255-116F4	51.35	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	50.84	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	37.21	0.70	0.09	1.14
Skeletal Muscle Cells, donor2	11358-117H8	54.94	4.34	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	20.90	0.00	0.00	3.34
Skeletal Muscle Cells, donor4	11451-119A2	45.56	1.10	0.79	1.89
Skeletal Muscle Cells, donor5	11455-119A6	33.89	0.45	0.00	1.49
Skeletal Muscle Cells, donor6	11459-119B1	22.78	0.15	0.31	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	17.77	0.88	0.13	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	26.11	0.43	0.14	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	28.27	0.79	0.00	1.98
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	20.73	0.59	0.34	0.93
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.82	1.45	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	37.98	0.14	0.55	1.10
Skin - palm, donor1	10286-104F7	32.23	10.74	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	17.44	2.59	1.44	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	17.18	4.09	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	13.50	2.08	0.65	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	45.59	11.40	3.61	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	24.19	4.50	1.97	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	9.30	1.06	1.06	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	44.45	10.72	2.77	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	110.78	2.78	1.85	2.47
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	30.68	0.67	0.89	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	39.38	1.18	0.59	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	40.66	1.55	0.22	4.86
Smooth Muscle Cells - Aortic, donor2	11360-117I1	84.27	4.33	1.18	1.97
Smooth Muscle Cells - Aortic, donor3	11432-118H1	44.81	1.55	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	11.01	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	43.65	1.73	0.80	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	47.66	0.66	0.00	2.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	68.88	1.92	0.64	1.54
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	49.49	1.63	0.00	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	39.87	1.18	0.00	1.48
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	48.69	1.57	0.43	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	61.00	0.98	0.16	1.46
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	72.76	0.91	0.00	2.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	25.76	0.25	0.00	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	54.84	0.00	0.00	2.38
Smooth Muscle Cells - Colonic, donor1	11239-116D6	22.56	0.59	0.15	1.18
Smooth Muscle Cells - Colonic, donor2	11320-117D6	29.06	0.86	0.22	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	29.60	1.26	0.10	1.05
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	77.80	5.26	0.62	1.70
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	67.91	3.23	3.23	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	59.17	1.20	0.60	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	24.58	0.34	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	13.11	0.00	0.00	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	54.25	2.11	0.70	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	78.05	5.01	0.91	2.05
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	83.93	3.62	2.42	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	24.37	0.79	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	38.22	0.40	0.53	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	31.18	0.75	0.13	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	112.37	4.31	0.25	3.04
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	75.39	3.92	0.60	2.41
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	64.51	3.75	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	55.57	0.00	0.00	45.23
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	31.62	0.47	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	54.53	2.02	0.00	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	67.69	1.88	1.88	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	81.12	3.24	0.59	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	15.00	0.33	0.17	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	86.89	0.93	0.93	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	55.12	4.17	0.58	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	44.62	1.02	0.51	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	51.15	0.75	0.00	1.88
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.14	0.42	0.14	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	26.39	0.42	0.00	1.01
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	109.05	2.38	0.00	2.38
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	55.54	4.89	2.45	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	50.82	1.10	0.00	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	83.38	2.93	0.59	2.05
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	48.78	0.97	0.00	1.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	115.30	3.70	0.53	2.64
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	79.60	2.60	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	83.37	1.44	0.72	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	111.86	3.69	0.85	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	35.45	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	87.36	3.81	0.25	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	51.91	1.60	0.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	81.51	3.34	0.84	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	71.05	0.46	0.00	1.83
Synoviocyte, donor1	11291-117A4	57.40	1.01	0.00	1.68
Synoviocyte, donor2	11368-117I9	69.06	1.01	0.34	1.84
Synoviocyte, donor3	11440-118H9	44.24	0.22	0.22	2.68
Trabecular Meshwork Cells, donor1	11532-120A2	19.30	0.36	0.00	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	87.21	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	37.74	0.46	0.00	1.85
Tracheal Epithelial Cells, donor1	11292-117A5	58.42	11.33	2.72	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	27.06	7.73	1.55	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	32.64	4.01	2.29	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	83.16	14.89	6.03	0.98
Urethra, donor2	10319-105A4	46.76	1.80	0.00	3.60
Urothelial Cells, donor1	11520-119H8	35.60	5.84	2.13	0.00
Urothelial Cells, donor2	11600-120H7	55.68	11.22	2.40	0.00
Urothelial Cells, donor3	11681-122H7	26.82	5.50	1.38	0.00
Urothelial cells, donor0	11216-116B1	22.51	3.12	0.89	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	92.54	4.45	4.45	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	138.67	15.73	4.29	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	106.10	13.69	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	46.83	3.79	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	64.49	2.91	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	108.29	10.41	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	95.45	14.68	4.59	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	102.24	13.69	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	101.03	9.01	1.85	0.49
Wilms' tumor cell line:HFWT	10597-108E3	68.64	8.80	1.76	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	50.28	3.63	1.68	0.28
achilles tendon, donor2	10292-104G4	66.13	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	28.30	0.76	0.00	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	26.35	0.47	0.36	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	61.50	2.72	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.21	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	7.05	0.00	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	30.22	0.00	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	4.27	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	56.86	0.74	0.18	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.46	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	6.99	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	5.55	0.00	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	29.74	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	39.48	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	11.97	0.61	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	14.08	0.00	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	16.07	0.00	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	15.41	0.00	0.00	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	5.57	0.00	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	28.69	1.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	53.89	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1.13	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.87	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	7.50	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	354.43	108.09	63.58	0.47
adipose tissue, adult, pool1	10010-101C1	141.78	3.26	1.24	2.17
adipose, donor1	10184-103D4	65.68	1.76	0.59	0.59
adipose, donor2	10185-103D5	84.75	2.03	1.22	0.81
adipose, donor3	10186-103D6	61.81	2.72	0.54	1.63
adipose, donor4	10187-103D7	29.47	2.60	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	72.91	1.42	0.47	1.58
adrenal gland, adult, pool1	10081-102A9	134.59	14.55	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	65.64	3.47	0.93	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	176.86	10.72	3.93	2.14
amniotic membrane cells, donor1	12235-129G3	15.30	3.25	0.93	0.00
amniotic membrane cells, donor2	12236-129G4	7.44	0.68	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	10.02	0.88	1.47	0.00
amygdala - adult, donor10196	10167-103B5	138.74	5.93	0.00	2.37
amygdala, adult, donor10252	10151-102I7	147.21	3.45	0.41	2.03
amygdala, newborn, donor10223	10360-105E9	53.58	1.61	0.97	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	14.64	0.13	0.00	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	29.12	0.88	0.22	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	25.39	1.67	4.68	0.33
aorta, adult, pool1	10052-101G7	126.70	5.69	3.14	1.77
appendix, adult	10189-103D9	67.53	15.91	13.58	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	215.30	53.31	22.01	0.00
artery, adult	10190-103E1	184.78	42.12	36.68	1.36
astrocytoma cell line:TM-31	10425-106D2	34.04	3.33	0.72	0.58
b cell line:RPMI1788	10427-106D4	77.47	5.20	0.00	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	66.31	1.11	0.83	4.44
bile duct carcinoma cell line:HuCCT1	10432-106D9	64.90	15.28	6.55	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	70.63	25.78	14.23	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	26.28	0.00	0.00	1.12
bladder, adult, pool1	10011-101C2	79.42	9.02	2.93	0.87
blood, adult, pool1	10053-101G8	46.51	8.86	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	0.00	0.00	0.00
bone marrow, adult	10192-103E3	88.40	0.67	1.35	2.02
brain, adult, donor1	10084-102B3	88.16	4.10	3.08	2.05
brain, adult, pool1	10012-101C3	85.52	3.01	0.67	1.67
brain, fetal, pool1	10085-102B4	53.43	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	51.87	1.98	0.33	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	31.46	2.12	0.37	0.50
breast, adult, donor1	10080-102A8	226.66	4.42	0.00	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	75.71	9.91	2.92	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	31.85	3.09	0.62	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	153.79	5.76	2.07	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	62.94	6.54	2.18	0.24
carcinoid cell line:NCI-H1770	10703-109H1	54.54	1.41	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	225.76	46.16	17.83	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	71.62	2.54	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	83.05	1.33	0.27	1.86
caudate nucleus - adult, donor10196	10177-103C6	166.94	6.91	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	135.03	4.18	1.84	1.34
caudate nucleus, adult, donor10258	10379-105H1	171.17	4.58	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	87.16	5.49	1.10	5.13
cerebellum - adult, donor10196	10173-103C2	119.44	2.91	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	85.83	2.35	0.43	0.43
cerebellum, adult, pool1	10083-102B2	70.37	5.86	1.72	2.41
cerebellum, newborn, donor10223	10357-105E6	43.17	13.28	3.32	0.83
cerebral meninges, adult	10188-103D8	123.80	6.81	3.03	1.51
cerebrospinal fluid, donor2	10294-104G6	133.02	10.96	1.46	2.19
cervical cancer cell line:D98-AH2	10552-107I3	150.83	22.29	5.90	0.43
cervical cancer cell line:ME-180	10553-107I4	82.69	43.25	31.65	0.33
cervix, adult, pool1	10013-101C4	52.60	2.41	0.31	1.47
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	50.58	2.37	0.42	1.39
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	0.00	1.31	2.61
choriocarcinoma cell line:BeWo	10423-106C9	84.01	16.90	6.71	0.87
choriocarcinoma cell line:SCH	10785-110H2	155.00	35.49	8.62	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	45.06	5.46	0.95	0.71
chorionic membrane cells, donor1	12238-129G6	15.67	0.57	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	33.91	1.29	0.89	0.40
chorionic membrane cells, donor3	12240-129G8	15.94	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	76.74	5.05	8.08	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	0.96	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	12.46	0.21	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	154.34	8.47	3.08	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	142.71	7.01	3.39	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	145.17	7.33	2.04	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	83.04	6.18	0.88	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	3.91	0.26	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	243.21	16.23	1.83	2.06
clear cell carcinoma cell line:TEN	10636-108I6	151.47	13.53	6.59	1.74
colon carcinoma cell line:CACO-2	10513-107D9	103.05	33.13	19.59	0.18
colon carcinoma cell line:COLO-320	10420-106C6	41.81	1.90	0.38	0.38
colon, adult, donor1	10082-102B1	105.91	26.18	15.47	4.76
colon, adult, pool1	10014-101C5	101.17	40.77	53.23	1.18
colon, fetal, donor1	10070-101I7	82.19	8.03	6.18	0.62
common myeloid progenitor CMP, donor1	12130-128D6	18.33	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	98.58	33.99	15.30	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	75.31	15.09	3.32	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	71.77	14.52	4.65	0.42
corpus callosum, adult, pool1	10042-101F6	86.35	5.09	2.43	1.77
cruciate ligament, donor2	10295-104G7	76.18	4.86	0.00	2.43
diaphragm, fetal, donor1	10069-101I6	142.05	32.10	15.25	4.82
diencephalon, adult	10193-103E4	83.04	4.80	0.72	1.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	10.33	0.46	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	64.11	11.03	11.28	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	110.25	9.87	4.81	1.93
ductus deferens, adult	10196-103E7	64.29	5.48	2.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	118.10	51.85	20.16	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	170.67	58.85	31.63	1.47
dura mater, adult, donor1	10041-101F5	67.23	1.90	0.41	1.82
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	41.53	6.00	6.44	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	48.00	3.15	1.43	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	70.29	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	68.72	1.21	0.61	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	66.38	2.47	0.62	0.93
embryonic pancreas cell line:2C6	10603-108E9	77.49	1.31	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	140.45	22.12	6.37	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	159.12	4.17	1.27	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	155.67	24.60	7.88	0.48
epidermoid carcinoma cell line:A431	10426-106D3	31.35	8.23	6.89	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	11.66	1.43	0.55	0.00
epididymis, adult	10197-103E8	92.93	12.98	6.70	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	35.13	2.31	0.35	1.60
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	80.61	2.75	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	129.35	20.57	8.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	137.10	24.70	11.12	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	132.53	20.73	10.42	0.45
esophagus, adult, pool1	10015-101C6	52.77	4.35	1.27	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	88.29	6.39	1.00	0.75
eye - muscle inferior rectus, donor1	10272-104E2	67.61	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	79.96	6.31	8.42	0.00
eye - muscle medial, donor2	10299-104H2	80.36	8.93	2.98	0.00
eye - muscle superior, donor2	10297-104G9	75.67	1.15	3.44	1.15
eye - vitreous humor, donor1	10268-104D7	21.86	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	85.42	14.49	3.31	2.54
fibrosarcoma cell line:HT-1080	10758-110E2	18.21	0.13	0.00	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	83.10	1.90	0.24	2.14
frontal lobe, adult, pool1	10040-101F4	77.40	2.91	0.47	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	138.72	64.55	24.62	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	58.24	4.57	0.73	0.82
gall bladder, adult	10198-103E9	233.47	121.44	67.36	0.48
gamma delta positive T cells, donor1	11937-126A2	7.52	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	7.47	0.75	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	64.21	7.60	3.59	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	205.79	72.92	31.91	1.16
gastric cancer cell line:AZ521	10549-107H9	73.62	4.59	2.46	0.33
gastric cancer cell line:GSS	10560-108A2	52.17	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	117.66	6.40	1.83	2.74
giant cell carcinoma cell line:LU65	10487-107B1	326.90	85.14	26.62	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	63.26	1.68	0.56	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.93	5.74	2.99	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	32.19	0.95	0.63	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	27.53	0.84	0.56	0.42
glioblastoma cell line:T98G	10485-107A8	16.78	0.33	0.11	0.77
glioma cell line:GI-1	10413-106B8	21.38	0.00	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	151.61	2.19	0.00	2.92
globus pallidus, adult, donor10252	10161-103A8	128.39	2.93	0.49	1.46
globus pallidus, adult, donor10258	10367-105F7	90.37	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	57.02	2.13	1.07	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	7.34	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	68.48	4.80	0.64	2.88
hIPS +CCl2, biol_rep1	14383-156B9	54.63	5.51	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	51.21	3.20	3.66	0.00
hIPS +CCl2, biol_rep3	14385-156C2	44.44	2.58	2.58	0.00
hIPS, biol_rep1	14380-156B6	80.49	1.44	1.44	0.00
hIPS, biol_rep2	14381-156B7	39.09	6.17	2.74	1.37
hIPS, biol_rep3	14382-156B8	147.86	5.52	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	148.56	10.34	2.30	2.59
heart - mitral valve, adult	10205-103F7	114.21	5.68	0.90	2.39
heart - pulmonic valve, adult	10206-103F8	94.65	3.14	0.26	1.05
heart - tricuspid valve, adult	10207-103F9	68.28	3.33	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	109.58	13.47	3.26	1.02
heart, adult, diseased, donor1	10051-101G6	140.52	5.96	0.43	1.70
heart, adult, pool1	10016-101C7	106.48	6.44	1.61	2.30
heart, fetal, pool1	10046-101G1	90.56	9.24	1.13	2.05
hepatic mesenchymal tumor cell line:LI90	10778-110G4	44.74	0.62	0.00	1.54
hepatoblastoma cell line:HuH-6	10633-108I3	33.30	3.57	2.38	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	77.57	7.51	2.43	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	73.07	8.74	3.16	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	77.51	11.12	2.73	0.40
hepatoma cell line:Li-7	10484-107A7	215.98	36.81	17.24	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	67.84	6.33	2.31	0.50
hippocampus - adult, donor10196	10169-103B7	103.15	2.84	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	175.32	6.53	0.61	3.47
hippocampus, adult, donor10258	10374-105G5	87.64	2.49	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	39.48	1.06	0.70	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	55.54	5.49	2.44	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	45.75	3.93	0.79	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	42.91	2.79	3.05	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	80.07	1.13	0.56	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	96.31	5.42	1.03	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	100.60	2.28	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	54.60	2.34	0.88	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	59.67	2.15	0.65	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	46.71	1.67	0.42	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	49.73	2.84	1.18	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	62.84	2.25	0.96	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	40.40	4.04	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	30.83	3.60	2.19	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	49.62	4.91	2.95	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	43.64	3.49	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	91.26	4.39	1.72	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	82.85	2.62	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	89.96	1.00	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	97.59	3.77	0.75	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	129.59	5.91	0.91	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	101.18	4.07	1.25	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	89.49	3.10	1.80	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	107.12	3.77	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	98.94	2.09	1.20	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	50.44	4.80	2.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	45.07	7.70	2.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	51.45	4.08	3.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	82.03	3.52	1.41	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	70.95	1.90	0.32	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	88.67	2.42	1.51	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	75.50	3.10	0.52	4.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	98.96	3.98	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	74.65	3.85	0.51	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	78.74	3.58	0.77	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	96.92	4.54	2.27	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	78.30	5.71	1.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	48.54	3.62	3.38	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	44.12	3.57	4.90	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	44.88	3.90	3.41	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	69.99	4.58	1.22	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	68.32	9.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	91.34	4.63	1.65	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	77.72	1.64	1.09	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	74.19	2.53	0.36	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	71.89	0.71	2.85	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	76.38	4.77	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	80.71	3.93	0.95	1.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	65.46	1.89	0.81	1.89
immature langerhans cells, donor1	11904-125F5	132.45	17.68	9.44	0.00
immature langerhans cells, donor2	11905-125F6	144.96	16.63	22.97	0.79
insula, adult, pool1	10039-101F3	94.25	3.60	0.57	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	7.48	1.63	0.98	0.00
kidney, adult, pool1	10017-101C8	264.04	63.08	41.15	1.90
kidney, fetal, pool1	10045-101F9	168.49	40.53	23.34	1.77
large cell lung carcinoma cell line:IA-LM	10509-107D5	7.81	0.43	0.28	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	69.81	1.52	0.55	1.80
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	61.29	7.52	2.02	0.55
left atrium, adult, donor1	10079-102A7	98.62	2.72	0.00	0.00
left ventricle, adult, donor1	10078-102A6	104.67	4.05	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	43.78	1.37	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	163.46	9.70	2.51	1.44
leiomyoma cell line:15242A	10570-108B3	155.44	5.43	5.98	0.54
leiomyoma cell line:15425	10571-108B4	122.14	3.40	2.43	1.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	28.23	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	59.38	3.42	0.94	0.94
liposarcoma cell line:KMLS-1	10782-110G8	17.65	0.31	0.00	1.09
liposarcoma cell line:SW 872	10726-110A6	30.09	0.49	0.37	0.73
liver, adult, pool1	10018-101C9	63.20	5.02	2.43	0.81
liver, fetal, pool1	10086-102B5	73.38	6.58	0.94	1.88
locus coeruleus - adult, donor10196	10182-103D2	132.99	4.23	0.44	2.92
locus coeruleus, adult, donor10252	10165-103B3	133.80	4.98	0.37	2.40
locus coeruleus, adult, donor10258	10375-105G6	141.92	4.23	3.95	2.26
locus coeruleus, newborn, donor10223	10362-105F2	74.03	4.63	2.10	0.42
lung adenocarcinoma cell line:A549	10499-107C4	118.05	11.35	4.15	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	17.24	0.69	1.38	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	47.45	3.56	0.92	0.13
lung, adult, pool1	10019-101D1	165.38	29.89	12.52	1.18
lung, fetal, donor1	10068-101I5	166.39	28.54	11.13	4.57
lung, right lower lobe, adult, donor1	10075-102A3	141.13	16.50	7.33	0.92
lymph node, adult, donor1	10077-102A5	71.00	3.79	1.89	1.42
lymphangiectasia cell line:DS-1	10727-110A7	84.82	5.92	2.85	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	79.09	8.75	4.23	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	39.93	14.44	4.25	0.00
mature adipocyte, donor1	12231-129F8	143.85	7.10	1.33	1.33
mature adipocyte, donor2	12232-129F9	183.04	5.60	1.25	1.87
mature adipocyte, donor3	12233-129G1	186.33	7.11	0.95	1.66
mature adipocyte, donor4	12234-129G2	171.09	7.37	1.32	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	62.19	9.53	3.81	2.14
medial frontal gyrus - adult, donor10196	10170-103B8	156.80	3.38	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	132.78	4.60	0.18	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	109.28	2.54	1.27	2.86
medial frontal gyrus, newborn, donor10223	10352-105E1	58.43	2.99	3.84	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	150.02	4.22	0.68	1.69
medial temporal gyrus, adult, donor10252	10156-103A3	142.19	5.09	0.64	2.97
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	111.72	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	68.91	2.87	2.15	0.36
medulla oblongata - adult, donor10196	10174-103C3	232.98	15.58	2.60	6.49
medulla oblongata, adult, donor10252	10155-103A2	170.28	9.44	1.86	2.01
medulla oblongata, adult, pool1	10038-101F2	101.05	6.53	3.43	1.31
medulla oblongata, newborn, donor10223	10361-105F1	87.84	2.08	0.35	2.78
medulloblastoma cell line:D283 Med	10838-111E1	36.09	0.66	1.11	1.11
medulloblastoma cell line:ONS-76	10759-110E3	34.97	2.20	0.24	0.61
melanoma cell line:COLO 679	10514-107E1	94.73	6.61	0.86	1.72
melanoma cell line:G-361	10465-106H6	59.45	8.42	0.54	0.54
meningioma cell line:HKBMM	10691-109F7	43.42	2.71	0.18	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	84.59	4.41	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	15.29	1.81	0.78	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	51.09	0.77	0.15	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	45.63	1.64	0.36	1.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	82.82	2.90	0.41	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	84.57	1.55	0.56	1.40
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	92.05	2.12	0.39	2.12
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	106.89	4.86	4.16	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	151.90	7.38	1.89	3.60
mesenchymal precursor cell - cardiac, donor2	11753-123G7	116.97	5.64	1.84	2.76
mesenchymal precursor cell - cardiac, donor3	11754-123G8	36.74	0.93	0.00	1.19
mesenchymal precursor cell - cardiac, donor4	11755-123G9	73.19	2.70	0.68	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	54.49	3.84	1.28	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	71.14	1.32	0.66	3.62
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	47.88	2.77	1.11	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	81.34	2.09	0.00	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	68.40	1.63	0.20	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	91.30	5.39	2.16	2.16
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	104.28	4.03	1.24	1.76
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	127.45	16.87	4.33	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	81.81	7.55	3.78	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	34.82	1.64	0.15	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	113.70	11.38	2.63	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	186.29	3.68	0.37	2.95
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	55.23	1.72	0.86	2.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	58.91	0.91	0.91	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	48.09	0.77	0.26	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	51.57	1.05	0.26	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	53.92	2.16	0.62	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	41.19	1.18	0.24	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	51.78	1.69	1.02	3.38
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	55.41	1.18	0.39	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	51.90	0.46	0.00	2.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	54.51	1.73	0.29	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	49.31	2.01	0.67	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	54.56	2.40	0.96	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	45.47	0.73	0.00	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	58.07	0.67	0.67	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	67.96	0.00	0.00	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	57.56	0.00	0.43	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	51.95	0.00	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	61.98	0.00	0.00	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	58.14	1.95	0.32	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	65.47	2.91	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	58.64	0.53	0.53	3.73
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	43.34	0.82	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	54.81	1.94	0.39	2.72
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	46.17	0.00	0.00	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	61.59	1.99	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	66.74	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	48.03	1.78	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	51.18	6.09	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	65.24	3.80	0.63	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	36.21	1.38	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	34.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	27.71	1.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	28.60	0.00	0.00	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	56.59	2.36	0.00	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	46.76	1.25	1.25	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	52.13	0.00	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	89.88	0.00	0.00	4.73
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	120.70	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	103.95	5.51	0.69	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	141.51	6.93	1.48	7.42
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	121.12	6.73	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	145.66	3.82	1.27	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	249.85	16.52	2.42	4.84
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	239.86	19.63	6.54	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	197.66	20.27	2.53	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	278.56	21.85	6.68	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	384.11	13.56	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	288.29	27.18	4.94	4.94
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	86.12	3.57	0.79	1.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	91.83	2.60	0.65	4.22
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	111.03	5.09	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	14.70	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	262.70	14.41	3.07	3.07
mesothelioma cell line:ACC-MESO-4	10494-107B8	112.83	31.28	13.90	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	89.75	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	87.54	4.01	1.03	0.41
mesothelioma cell line:Mero-25	10850-111F4	156.14	12.26	3.40	2.27
mesothelioma cell line:Mero-41	10851-111F5	85.81	4.65	1.22	0.73
mesothelioma cell line:Mero-48a	10852-111F6	57.13	5.54	1.55	0.66
mesothelioma cell line:Mero-82	10853-111F7	60.45	4.20	1.31	1.05
mesothelioma cell line:Mero-83	10854-111F8	38.30	1.53	0.34	0.68
mesothelioma cell line:Mero-84	10855-111F9	154.44	23.26	9.61	0.51
mesothelioma cell line:Mero-95	10856-111G1	94.41	9.73	4.97	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	27.99	1.33	0.17	0.66
mesothelioma cell line:NCI-H226	10846-111E9	100.99	11.40	3.62	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	105.74	6.83	1.54	1.88
mesothelioma cell line:NCI-H28	10845-111E8	83.97	2.80	1.02	1.02
mesothelioma cell line:No36	10857-111G2	72.74	1.30	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	111.90	4.88	0.27	1.35
migratory langerhans cells, donor1	11901-125F2	236.06	9.21	2.69	1.73
migratory langerhans cells, donor2	11902-125F3	158.38	5.62	1.59	1.47
migratory langerhans cells, donor3	11903-125F4	197.79	8.26	1.26	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	74.11	2.61	0.65	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	47.69	3.39	0.42	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	107.58	32.48	14.51	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	25.88	0.19	0.95	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	32.52	0.74	0.18	1.85
myeloma cell line:PCM6	10474-106I6	46.25	3.56	0.99	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	39.57	0.00	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	62.57	1.18	0.00	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	151.65	44.90	8.47	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	156.42	47.58	12.06	0.22
nasal epithelial cells, donor2	12227-129F4	87.21	25.39	7.18	1.10
neuroblastoma cell line:CHP-134	10508-107D4	16.33	0.23	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	24.13	0.00	0.19	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	87.52	8.01	2.53	2.32
neuroblastoma cell line:NH-12	10555-107I6	22.92	0.00	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	30.60	0.71	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	62.56	1.11	0.00	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	44.08	0.40	0.20	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	71.84	1.91	0.00	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	32.74	0.27	0.27	1.06
neutrophil PMN, donor1	12133-128D9	238.00	0.00	29.75	0.00
neutrophil PMN, donor2	12137-128E4	464.82	146.09	66.40	0.00
neutrophil PMN, donor3	12141-128E8	947.06	179.94	75.77	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	22.83	0.51	0.17	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	32.82	4.80	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	41.68	1.28	0.64	3.21
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	15.24	0.26	0.00	0.53
nucleus accumbens, adult, pool1	10037-101F1	92.33	6.37	1.31	1.59
occipital cortex - adult, donor10196	10172-103C1	125.68	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	157.53	3.22	0.27	1.34
occipital cortex, newborn, donor10223	10355-105E4	65.87	0.36	1.09	0.73
occipital lobe, adult, donor1	10076-102A4	155.86	2.89	2.62	2.89
occipital lobe, fetal, donor1	10073-102A1	57.93	0.00	0.43	0.86
occipital pole, adult, pool1	10036-101E9	76.63	2.60	0.79	1.02
olfactory region, adult	10195-103E6	98.58	2.67	0.57	1.72
optic nerve, donor1	10277-104E7	22.01	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	30.53	9.57	5.92	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	43.00	3.02	2.47	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	35.90	5.93	1.52	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	32.46	4.04	0.58	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	19.40	0.00	0.29	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	40.18	1.87	0.00	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	41.35	0.85	0.00	1.70
ovary, adult, pool1	10020-101D2	60.80	3.41	1.14	1.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	33.73	1.65	0.55	2.75
pancreas, adult, donor1	10049-101G4	149.56	52.68	13.17	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	74.64	14.54	4.19	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	93.69	4.94	1.53	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	57.46	13.41	6.79	0.00
paracentral gyrus, adult, pool1	10035-101E8	78.43	4.30	0.92	0.82
parietal cortex, adult, donor10258	10373-105G4	84.41	3.67	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	104.39	2.82	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	125.13	4.56	0.29	1.43
parietal lobe, adult, pool1	10034-101E7	78.43	3.35	0.53	1.67
parietal lobe, fetal, donor1	10072-101I9	33.94	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	72.53	4.11	3.36	0.37
parotid gland, adult	10199-103F1	76.47	20.35	12.33	0.62
penis, adult	10200-103F2	140.19	14.50	7.52	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	142.80	2.42	0.19	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	86.25	10.93	2.48	1.46
pineal gland - adult, donor10196	10179-103C8	78.69	5.16	1.29	1.94
pineal gland, adult, donor10252	10160-103A7	65.74	2.37	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	82.15	1.25	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	201.35	39.46	9.11	0.00
pituitary gland, adult, donor10252	10162-103A9	96.94	29.71	6.25	0.52
pituitary gland, adult, donor10258	10378-105G9	119.17	19.58	11.92	0.00
placenta, adult, pool1	10021-101D3	41.82	8.28	4.09	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	83.16	2.65	0.66	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	5.60	0.00	0.16	0.47
pons, adult, pool1	10033-101E6	102.76	10.93	2.07	1.64
postcentral gyrus, adult, pool1	10032-101E5	81.60	2.70	0.35	1.92
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	110.16	16.52	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	0.00	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	90.02	8.59	4.37	0.29
prostate cancer cell line:PC-3	10439-106E7	56.08	8.71	2.00	0.36
prostate, adult, pool1	10022-101D4	50.42	5.62	1.72	0.82
putamen, adult, donor10196	10176-103C5	131.02	7.79	0.47	1.89
putamen, adult, donor10252	10152-102I8	90.19	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	102.72	3.28	1.09	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	115.97	5.07	0.48	2.42
putamen, newborn, donor10223	10365-105F5	104.20	3.00	1.50	3.00
rectal cancer cell line:TT1TKB	10469-106I1	65.75	31.13	13.38	0.00
rectum, fetal, donor1	10067-101I4	57.03	4.17	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	152.00	5.30	2.33	1.70
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	105.62	4.14	0.41	1.66
retina, adult, pool1	10030-101E3	170.87	22.46	5.77	1.79
retinoblastoma cell line:Y79	10475-106I7	54.04	2.34	0.00	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	75.24	5.29	0.98	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	16.31	0.00	0.56	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.80	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	25.41	2.75	0.81	0.16
salivary acinar cells, donor2	11772-123I8	29.47	2.75	2.07	0.41
salivary acinar cells, donor3	11773-123I9	19.86	0.66	1.32	0.00
salivary gland, adult, pool1	10093-102C3	63.49	20.59	24.59	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	71.92	2.87	0.34	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	74.06	2.35	0.24	0.71
seminal vesicle, adult	10201-103F3	46.56	3.17	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	73.85	17.73	4.62	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	197.03	5.28	1.51	3.52
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	79.28	2.01	0.00	5.02
serous cystadenocarcinoma cell line:HTOA	10693-109F9	121.02	16.66	6.04	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	104.67	32.83	17.68	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	448.88	170.31	175.60	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	238.34	55.33	46.82	0.71
skeletal muscle, adult, pool1	10023-101D5	208.81	68.24	46.78	1.08
skeletal muscle, fetal, donor1	10066-101I3	58.29	6.03	0.00	1.01
skin, adult, donor1	10074-102A2	74.64	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	88.37	4.42	1.89	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	77.38	9.34	3.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	22.38	4.41	1.26	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	56.09	0.39	0.19	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	26.37	2.47	0.99	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	50.19	0.48	0.32	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	32.91	5.67	3.92	0.00
small intestine, adult, pool1	10024-101D6	145.60	87.31	109.41	0.60
small intestine, fetal, donor1	10064-101I1	121.37	26.78	5.41	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	79.50	8.21	3.59	1.03
smooth muscle, adult, pool1	10048-101G3	62.29	0.78	0.78	1.29
somatostatinoma cell line:QGP-1	10781-110G7	54.41	12.87	3.48	0.00
spinal cord - adult, donor10196	10181-103D1	186.74	2.29	0.46	4.59
spinal cord, adult, donor10252	10159-103A6	115.52	4.73	1.18	0.79
spinal cord, adult, donor10258	10369-105F9	166.72	5.53	0.00	2.08
spinal cord, fetal, donor1	10056-101H2	75.62	1.83	1.83	2.44
spinal cord, newborn, donor10223	10359-105E8	60.16	2.76	0.46	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	39.28	0.90	0.45	1.34
spleen, adult, pool1	10025-101D7	50.77	3.08	0.77	0.66
spleen, fetal, pool1	10044-101F8	64.44	7.63	1.51	1.43
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	101.86	5.07	2.17	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	42.34	8.35	2.28	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	90.86	14.68	4.19	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	132.92	23.46	5.47	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	125.62	23.30	6.98	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	117.76	8.05	4.24	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	89.27	5.92	1.69	0.00
stomach, fetal, donor1	10062-101H8	672.82	275.54	193.30	4.27
submaxillary gland, adult	10202-103F4	52.98	11.96	9.68	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	128.99	2.49	0.42	2.91
substantia nigra, adult, donor10258	10371-105G2	149.49	4.14	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	50.87	0.71	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	30.49	1.15	0.23	0.69
temporal lobe, adult, pool1	10031-101E4	87.40	3.31	0.76	1.27
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	54.13	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	32.53	0.88	0.44	0.00
tenocyte, donor1	11763-123H8	53.06	0.35	0.35	1.75
tenocyte, donor2	11765-123I1	45.02	1.53	0.00	3.05
tenocyte, donor3	11768-123I4	41.14	0.00	0.00	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	72.23	2.38	0.68	1.70
teratocarcinoma cell line:NCR-G1	10798-110I6	107.13	5.24	1.54	1.23
teratocarcinoma cell line:PA-1	10807-111A6	61.22	2.32	0.46	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	47.61	11.30	2.92	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	20.04	2.65	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	44.28	10.14	5.45	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	57.98	4.56	2.93	0.65
testis, adult, pool1	10026-101D8	77.31	5.37	1.07	0.97
testis, adult, pool2	10096-102C6	138.03	11.73	0.90	1.80
thalamus - adult, donor10196	10168-103B6	144.62	1.10	1.10	3.31
thalamus, adult, donor10252	10154-103A1	116.12	3.91	0.16	2.81
thalamus, adult, donor10258, tech_rep1	10370-105G1	126.25	7.70	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	84.65	2.31	0.49	2.96
thalamus, newborn, donor10223	10366-105F6	59.83	2.88	0.58	1.73
throat, adult	10209-103G2	114.35	24.22	14.48	2.25
throat, fetal, donor1	10061-101H7	82.27	5.48	2.44	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	50.88	5.37	2.98	0.40
thymus, adult, pool1	10027-101D9	24.95	1.69	0.70	0.20
thymus, fetal, pool1	10043-101F7	43.64	4.68	0.52	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	134.96	4.25	0.93	3.59
thyroid carcinoma cell line:TCO-1	10783-110G9	120.83	3.91	1.40	1.68
thyroid, adult, pool1	10028-101E1	146.50	15.40	6.16	2.05
thyroid, fetal, donor1	10060-101H6	104.67	10.55	3.16	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	67.75	6.16	6.16	0.00
tongue, adult	10203-103F5	101.87	23.49	14.42	0.93
tongue, fetal, donor1	10059-101H5	150.15	40.20	13.01	0.39
tonsil, adult, pool1	10047-101G2	33.86	4.81	2.80	0.30
trachea, adult, pool1	10029-101E2	100.78	13.17	5.48	1.15
trachea, fetal, donor1	10058-101H4	88.48	15.00	4.62	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	40.39	0.71	0.35	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	24.01	3.34	0.81	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	66.12	2.98	1.72	0.47
tridermal teratoma cell line:HGRT	10694-109G1	3.81	0.00	1.90	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	140.01	17.61	6.26	0.68
umbilical cord, fetal, donor1	10057-101H3	77.20	6.26	4.17	0.00
uterus, adult, pool1	10100-102D1	78.83	2.90	0.85	1.54
uterus, fetal, donor1	10055-101H1	35.83	2.56	0.51	0.51
vagina, adult	10204-103F6	97.58	9.69	1.29	0.00
vein, adult	10191-103E2	72.99	5.70	2.85	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	75.84	1.60	0.27	0.00